Previous Close | 8.01 |
Open | 8.07 |
Bid | 7.91 x 100 |
Ask | 7.98 x 100 |
Day's Range | 7.93 - 8.08 |
52 Week Range | 7.44 - 11.71 |
Volume | |
Avg. Volume | 391,171 |
Market Cap | 388.441M |
Beta (5Y Monthly) | 0.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.95 |
Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.20 |
On August 31, 2024, The Baupost Group, led by renowned value investor Seth Klarman (Trades, Portfolio), executed a significant transaction by completely exiting its position in Theravance Biopharma Inc (NASDAQ:TBPH). This move has notably reduced the firm's exposure in the biotechnology sector, reflecting a strategic shift or reassessment of the stock's future potential.
Madrigal (MDGL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...